|
1
|
Virchow RL: Die Krankhalften Geschwulste.
A Hirschwald, Berlin Volume. 2:pp181–182. 1865.
|
|
2
|
Japan Esophageal Society, . Japanese
classification of esophageal cancer, 11th edition: Part II and III.
Esophagus. 14:37–65. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Kashiwabara K, Sano T, Oyama T, Najahima
T, Makita F, Hashimoto N, Iwanami K, Kawashima O, Matsumoto T and
Matsuzaki Y: A case of esophageal sarcomatoid carcinoma with
molecular evidence of a monoclonal origin. Pathol Res Pract.
197:41–46. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Handra-Luca A, Terris B, Couvelard A,
Molas G, Degott C and Flejou JF: Spindle cell squamous carcinoma of
the oesophagus: An analysis of 17 cases, with new
immunohistochemical evidence for a clonal origin. Histopathology.
39:125–132. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Matsumoto T, Fujii H, Arakawa A, Yamasaki
S, Sonoue H, Hattori K, Kajiyama Y, Hirose S and Tsurumaru M: Loss
of heterozygosity analysis shows monoclonal evolution with frequent
genetic progression and divergence in esophageal carcinosarcoma.
Hum Pathol. 35:322–327. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Larue L and Bellacosa A:
Epithelial-mesenchymal transition in development and cancer: Role
of phosphatidylinositol 3′ kinase/AKT pathways. Oncogene.
24:7443–7454. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Nieto MA: The ins and outs of the
epithelial to mesenchymal transition in health and disease. Annu
Rev Cell Dev Biol. 27:347–376. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Nakazawa T, Nobusawa S, Ikota H, Kuwano H,
Takeyoshi I and Yokoo H: Wide expression of ZEB1 in sarcomatous
component of spidle cell carcinoma of esophagus. Pathol Int.
65:635–643. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Brabletz S and Brabletz T: The ZEB/miR-200
feedback loop a motor of cellular plasticity in development and
cancer? EMBO Rep. 11:670–677. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Lim YY, Wright JA, Attema JL, Gregory PA,
Bert AG, Smith E, Thomas D, Lopez AF, Drew PA, Khew-Goodall Y and
Goodall GJ: Epigenetic modulation of the miR-200 family is
associated with transition to a breast cancer stem-cell-like state.
J Cell Sci. 126:2256–2266. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Zhou X, Wang Y, Shan B, Han J, Zhu H, Lv
Y, Fan X, Sang M, Liu XD and Liu W: The downregulation of
miR200c/141 promotes ZEB1/2 expression and gastric cancer
progression. Med Oncol. 32:4282015. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Sobin LH and Wittekind C: TNM
classification of malignant tumors. 6th. New York: Wiley-Liss;
2002
|
|
13
|
Kikuchi M, Yamashita K, Waraya M, Minatani
N, Ushiku H, Kojo K, Ema A, Kosaka Y, Katoh H, Sengoku N, et al:
Epigenetic regulation of ZEB1-RAB25/ESRP1 axis plays a critical
role in phenylbutyrate treatment-resistant breast cancer.
Oncotarget. 7:1741–1753. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Zhu DY, Guo QS, Li YL, Cui B, Guo J, Liu
JX and Li P: Twist1 correlates with poor differentiation and
progression in gastric adenocarcinoma via elevation of FGFR2
expression. World J Gastroenterol. 20:18306–18315. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Sung CO, Lee KW, Han S and Kim SH: Twist1
is up-regulated in gastric cancer-associated fibroblasts with poor
clinical outcomes. Am J Pathol. 179:1827–1838. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Dong H, Xie L, Tang C, Chen S, Liu Q,
Zhang Q, Zheng W, Zheng Z and Zhang H: Snail1 correlates with
patient outcomes in E-cadherin-preserved gastroesophageal junction
adenocarcinoma. Clin Transi Oncol. 16:783–791. 2014. View Article : Google Scholar
|
|
17
|
Yu J, Li J, Chen Y, Cao W, Lu Y, Yang J
and Xing E: Snail enhances glycolysis in the epithelial-mesenchymal
transition process by targeting FBP1 in gastric cancer. Cell
Physiol Biochem. 43:31–38. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Owens WD, Felts JA and Spitznagel EL Jr:
ASA physical status classifications: A study of consistency of
ratings. Anesthesiology. 49:239–243. 1978. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Dindo D, Demartines N and Clavien PA:
Classification of surgical complications: A new proposal with
evaluation in a cohort of 6336 patients and results of a survey.
Ann Surg. 240:205–213. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Kimura H, Konishi K, Kawamura T, Nojima N,
Satou T, Maeda K, Yabushita K, Kuroda Y, Tsuji M and Miwa A:
Esophageal sarcomas: Report of three cases. Dig Surg. 16:244–247.
1999. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Ji F, Xu YM and Xu CF: Endoscopic
polypectomy: A promising therapeutic choice for esophageal
carcinosarcoma. World J Gastroenterol. 15:3448–3450. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Wang L, Lin Y, Long H, Liu H, Rao H, He Y,
Rong T and Liang Y: Esophageal carcinosarcoma: A unique entity with
better prognosis. Ann Surg Oncol. 20:997–1004. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Takemura M, Osugi H, Takeda N, Okuda E,
Ueno M and Kinoshita H: Three cases of resected so-called
carcinosarcoma of the esophagus and review of the japanese
literature. J Jpn Surg Assoc. 62:659–664. 2001.(In Japanese).
View Article : Google Scholar
|
|
24
|
Sung CO, Choi H, Lee KW and Kim SH:
Sarcomatoid carcinoma represents a complete phenotype with various
pathways of epithelial mesenchymal transition. J Clin Pathol.
66:601–606. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Pang A, Carbini M, Moreira AL and Maki RG:
Carcinosarcomas and related cancers: Tumors caught in the act of
epithelial-mesenchymal transition. J Clin Oncol Dec. 36:210–216.
2018. View Article : Google Scholar
|
|
26
|
Viswanathan VS, Ryan MJ, Dhruv HD, Gill S,
Eichhoff OM, Seashore-Ludlow B, Kaffenberger SD, Eaton JK, Shimada
K, Aguirre AJ, et al: Dependency of a therapy-resistant state of
cancer cells on a lipid peroxidase pathway. Nature. 547:453–457.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Horiguchi K, Sakamoto K, Koinuma D, Semba
K, Inoue A, Inoue S, Fujii H, Yamaguchi A, Miyazawa K, Miyazono K
and Saitoh M: TGF-β drives epithelial-mesenchymal transition
through δEF1-mediated downregulation of ESRP. Oncogene.
31:3190–3201. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Joseph JV, Conroy S, Tomar T,
Eggens-Meijer E, Bhat K, Copray S, Walenkamp AM, Boddeke E,
Balasubramanyian V, Wagemakers M, et al: TGF-β is an inducer of
ZEB1-dependent mesenchymal transdifferentiation in glioblastoma
that is associated with tumor invasion. Cell Death Dis.
5:e14432014. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Korpal M, Lee ES, Hu G and Kang Y: The
miR-200 family inhibits epithelial-mesenchymal transition and
cancer cell migration by direct targeting of E-cadherin
transcriptional repressors ZEB1 and ZEB2. J Biol Chem.
283:14910–14914. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Gregory PA, Bert AG, Paterson EL, Barry
SC, Tsykin A, Farshid G, Vadas MA, Khew-Goodall Y and Goodall GJ:
The miR-200 family and miR-205 regulate epithelial to mesenchymal
transition by targeting ZEB1 and SIP1. Nat Cell Biol. 10:593–601.
2008. View
Article : Google Scholar : PubMed/NCBI
|
|
31
|
Park SM, Gaur AB, Lengyel E and Peter ME:
The miR-200 family determines the epithelial phenotype of cancer
cells by targeting the E-cadherin repressors ZEB1 and ZEB2. Gene
Dev. 22:894–907. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Zhang B, Xiao Q, Yang D, Li X, Hu J, Wang
Y and Wang W: Spindle cell carcinoma of the esophagus: A
multicenter analysis in comparison with typical squamous cell
carcinoma. Medicine (Baltimore). 95:e47682016. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Aigner K, Dampier B, Descovich L, Mikula
M, Sultan A, Schreiber M, Mikuliys W, Brabletz T, Strand D, Obrist
P, et al: The transcription factor ZEB1 (deltaEF1) promotes tumour
cell dedifferentiation by repressing master regulators of
epithelial polarity. Oncogene. 26:6979–6988. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Arima Y, Hayashi H, Sasaki M, Hosonaga M,
Goto T, Chiyoda T, Kuninaka S, Shibata T, Ohata H, Nakagama H, et
al: Induction of ZEB proteins by inactivation of RB protein is key
determinant of mesenchymal phenotype of breast cancer. J Biol Chem.
287:7896–7906. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Spaderna S, Schmalhofer O, Wahlbuhl M,
Dimmler A, Bauer K, Sultan A, Hlubek F, Jung A, Strand D, Eger A,
et al: The transcriptional repressor ZEB1 promotes metastasis and
loss of cell polarity in cancer. Cancer Res. 68:537–544. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Arumugam T, Ramachandran V, Fournier KF,
Wang H, Marquis L, Abbruzzese JL, Gallick GE, Logsdon CD, McConkey
DJ and Choi W: Epithelial to mesenchymal transition contributes to
drug resistance in pancreatic cancer. Cancer Res. 69:5820–5828.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Sanada Y, Hihara J, Yoshida K and
Yamaguchi Y: Esophageal carcinosarcoma with intramural metastasis.
Dis Esophagus. 19:119–131. 2006. View Article : Google Scholar : PubMed/NCBI
|
